MiR‐381 directly targets Cullin 4B (CUL4B), an oncogene overexpressed in various cancers, and downregulates the expression of β‐catenin as well as c‐MYC and cyclin D1 in gastric cancer cells. This evidence concerns the gene CUL4B and cancer.